Previous 10 | Next 10 |
Poster to be presented on back-of-the-eye program including data from uveitis preclinical model Interim data expected from Akari’s Phase I/II clinical trial in atopic keratoconjunctivitis (AKC), a surface of the eye inflammatory disease NEW YORK and LONDON, March 27, 2019 ...
Akari Therapeutics (NASDAQ: AKTX ) has filed a prospectus for the sale by holder Aspire Capital Fund of 500M ordinary shares . More news on: Akari Therapeutics, Plc, Healthcare stocks news, Stocks on the move, Read more ...
Altimmune (NASDAQ: ALT ) +44% on positive NasoVAX data . More news on: Altimmune, Inc., Vaxart, Inc., Cellectar Biosciences, Inc., Stocks on the move, Read more ...
CORAL GABLES, FL / ACCESSWIRE / March 18, 2019 / The tech stock market is truly miraculous, mainly because the tech industry never ceases to amaze consumers as companies consistently demonstrate their ability to innovate towards the future. Over the course of the last few months, we've see...
Gainers: Dermira (NASDAQ: DERM ) +85% . PhaseBio Pharmaceuticals (NASDAQ: PHAS ) +48% . Atossa Genetics (NASDAQ: ATOS ) +35% . American Midstream Partners (NYSE: AMID ) +28% . Aclaris Therapeutics (NASDAQ: ACRS ) +21% . Innovate Biopharmaceuticals (NASDAQ: INNT ) +20% . Profess...
PhaseBio Pharmaceuticals (NASDAQ: PHAS ) +108% on positive PB2452 data . More news on: PhaseBio Pharmaceuticals, Inc., Dermira, Inc., Leap Therapeutics, Inc., Stocks on the move, Read more ...
Kopin (NASDAQ: KOPN ) -24% on secondary offering . More news on: Kopin Corporation, PHI, Inc., Yield10 Bioscience, Inc., Stocks on the move, Read more ...
Gainers: Atossa Genetics (NASDAQ: ATOS ) +242% . Hancock Jaffe Laboratories (NASDAQ: HJLI ) +41% . WageWorks (NYSE: WAGE ) +30%. Smith Micro Software (NASDAQ: SMSI ) +31% . Akari Therapeutics (NASDAQ: AKTX ) +30% . KalVista Pharmaceuticals (NASDAQ: KALV ) +29% . MongoDB (NASDA...
Atossa Genetics (NASDAQ: ATOS ) +223% on expanded access for Endoxifen. More news on: Atossa Genetics Inc., Hancock Jaffe Laboratories, Inc., Safe-T Group Ltd, Stocks on the move, Read more ...
March 14, 2019 Palm Beach, FL – March 14, 2019 – According to the Leukemia & Lymphoma Society, the world’s largest voluntary health agency dedicated to blood cancer, In 2018, 60,300 people are expected to be diagnosed with leukemia and that there are an estimat...
News, Short Squeeze, Breakout and More Instantly...
Akari Therapeutics Plc Company Name:
AKTX Stock Symbol:
NASDAQ Market:
Akari Therapeutics Plc Website:
Interim CEO employment contract consists solely of equity compensation Samir R. Patel, M.D., increases ownership to 14.2% with $1.25m investment in recent private placement BOSTON and LONDON, June 05, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotec...
BOSTON and LONDON, June 04, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), an innovative biotechnology company advancing therapies for autoimmune and inflammatory diseases, today announced the successful initial closing of a private placement financing round. This transaction is ...
Entered into a Definitive Merger Agreement with Peak Bio; Expected to Close in the Third Quarter of 2024 Samir R. Patel, M.D. Appointed Interim CEO Plan for Prioritization of Peak Bio’s ADC Cancer Therapeutic Platform Technology and Akari’s PAS-nomacopan fo...